Paper15085484
The pathology of cholestasis.
Li MK and 1 other. Semin Liver Dis, 2004. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. The pathology of cholestasis. Papers, record 15085484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15085484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholestasis | Major topic |
| Liver | Major topic |
| Liver Transplantation | Major topic |
| Pregnancy Complications | Major topic |
| Adolescent | |
| Adult | |
| Bile Ducts | |
| Biopsy | |
| Child | |
| Child, Preschool | |
| Cholangitis, Sclerosing | |
| Female | |
| Hepatocytes | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Liver Cirrhosis, Biliary | |
| Liver Failure | |
| Male | |
| Pregnancy |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42687554 | Obeticholic Acid and Edaravone Protect Against Cisplatin-Induced Hepatotoxicity Through Modulation of Keap1/Nrf2/ARE, TNF-α/NF-κB, and AKT/GSK-3β Pathways. | J Biochem Mol Toxicol | 2026 | https://conductscience.org/library/papers/42687554 | PubMed |
| 40956601 | The interaction between IL-17 and gut microbiota contributes to cholestatic liver disease in children. | Microbiology (Reading) | 2025 | https://conductscience.org/library/papers/40956601 | PubMed |
| 39198465 | Generation of human iPSC-derived 3D bile duct within liver organoid by incorporating human iPSC-derived blood vessel. | Nat Commun | 2024 | https://conductscience.org/library/papers/39198465 | PubMed |
| 38950046 | Comparing animal well-being between bile duct ligation models. | PLoS One | 2024 | https://conductscience.org/library/papers/38950046 | PubMed |
| 38654111 | Multiscale X-ray phase-contrast CT unveils the evolution of bile infarct in obstructive biliary disease. | Commun Biol | 2024 | https://conductscience.org/library/papers/38654111 | PubMed |
| 38612495 | Discrimination of Etiologically Different Cholestasis by Modeling Proteomics Datasets. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612495 | PubMed |
| 38003277 | Integrated Transcriptome and Metabolomics to Reveal the Mechanism of Adipose Mesenchymal Stem Cells in Treating Liver Fibrosis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003277 | PubMed |
| 36656901 | Hepatic ribosomal protein S6 (Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a ribosomopathy-like phenotype that is partially p53-dependent. | PLoS Genet | 2023 | https://conductscience.org/library/papers/36656901 | PubMed |
| 36384146 | Non-alcoholic fatty liver disease: the pathologist's perspective. | Clin Mol Hepatol | 2023 | https://conductscience.org/library/papers/36384146 | PubMed |
| 36292464 | Protocols of Investigation of Neonatal Cholestasis-A Critical Appraisal. | Healthcare (Basel) | 2022 | https://conductscience.org/library/papers/36292464 | PubMed |
| 35881613 | Species specific morphological alterations in liver tissue after biliary occlusion in rat and mouse: Similar but different. | PLoS One | 2022 | https://conductscience.org/library/papers/35881613 | PubMed |
| 35677523 | Corrosion Cast and 3D Reconstruction of the Murine Biliary Tree After Biliary Obstruction: Quantitative Assessment and Comparison With 2D Histology. | J Clin Exp Hepatol | 2022 | https://conductscience.org/library/papers/35677523 | PubMed |
| 35624784 | Substance P Hinders Bile Acid-Induced Hepatocellular Injury by Modulating Oxidative Stress and Inflammation. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624784 | PubMed |
| 35548189 | The Interplay Between Biliary Occlusion and Liver Regeneration: Repeated Regeneration Stimuli Restore Biliary Drainage by Promoting Hepatobiliary Remodeling in a Rat Model. | Front Surg | 2022 | https://conductscience.org/library/papers/35548189 | PubMed |
| 35359065 | [Expert consensus on the diagnosis and treatment of intrahepatic cholestasis (2021 edition)]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/35359065 | PubMed |
| 34943592 | Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34943592 | PubMed |
| 34867446 | Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression. | Front Physiol | 2021 | https://conductscience.org/library/papers/34867446 | PubMed |
| 34458174 | Histomorphometric analysis of liver biopsies of treated patients with Gaucher disease type 1. | Autops Case Rep | 2021 | https://conductscience.org/library/papers/34458174 | PubMed |
| 34188935 | Rainbow of colors: Inspissated bile syndrome secondary to hemolytic disease of the newborn and concomitant serum dynamics. | SAGE Open Med Case Rep | 2021 | https://conductscience.org/library/papers/34188935 | PubMed |
| 33946877 | High Rate of Gastrointestinal Bleeding in Patients with Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP). | J Clin Med | 2021 | https://conductscience.org/library/papers/33946877 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15085484
GET https://conductscience.org/api/papers/v1/15085484/cited_by?page=2